图书馆订阅: Guest
Begell Digital Portal Begell 数字图书馆 电子图书 期刊 参考文献及会议录 研究收集
免疫学评论综述™
影响因子: 1.352 5年影响因子: 3.347 SJR: 0.657 SNIP: 0.55 CiteScore™: 2.19

ISSN 打印: 1040-8401
ISSN 在线: 2162-6472

免疫学评论综述™

DOI: 10.1615/CritRevImmunol.v17.i1.20
pages 33-75

Autoimmune Pathogenesis of Multiple Sclerosis: Role of Autoreactive T Lymphocytes and New Immunotherapeutic Strategies

Piet Stinissen
Hasselt University, Biomedical Research Institute and Transnationale Universiteit Limburg, School of Life Sciences, Diepenbeek, Belgium
Jef Raus
Biomedisch Onderzoeksinstituut, Limburgs Universitair Centrum and School of Life Sciences, Transnational University Limburg, Universitaire Campus A, B-3590 Diepenbeek, Belgium
Jingwu Zhang
Multiple Sclerosis and Immunology Unit, Dr. L. Willems-lnstituut and Limburgs Universitair Centrum (LUC), Universitaire Campus, B-3590 Diepenbeek, Belgium

ABSTRACT

Accumulating evidence indicates that multiple sclerosis (MS) is an autoimmune disease mediated by autoreactive T lymphocytes with specificity for myelin antigens. Initially, the evidence to support this hypothesis was based mainly on experiments performed in experimental allergic encephalomyelitis (EAE), the animal model of MS. In this model it was demonstrated that T cells reactive to several myelin antigens are encephalitogenic. Many recent immunological and immunohistohemical studies in MS have yielded further data to support this view. For instance, it was demonstrated that activated myelin basic protein (MBP) and proteolipid protein (PLP)-specific T cells accumulate in the central nervous system (CNS), and that clonally expanded MBP-specific T cells persist for several years in the blood of patients with MS. Furthermore, T cells with specificity for MBP were identified in the brain lesions of the patients. It is not yet clear how these autoreactive T cells are activated in the periphery, but several studies have suggested that viral antigens mimicking the myelin epitopes, or superantigens may be involved. Furthermore, we and others have provided evidence showing that the regulatory mechanisms that control autoreactive T cells in healthy subjects are potentially defective in MS patients. In addition to myelin reactive T cells, B cells producing myelin-specific antibodies and γδ T cells may also play an important role in the autoimmune cascade. Based on the recent insights in the disease mechanisms, new experimental therapies were developed to target specifically the pathogenic lymphocytes in MS. Some therapies yielded encouraging data in pilot studies, whereas phase III trials of other drugs showed beneficial effects on the disease course. In this article, we overview the most recent data on the role of autoreactive lymphocytes in the pathogenesis of the disease, and discuss some of the recently developed immunotherapeutical strategies in MS.


Articles with similar content:

Immune-Mediated Oligodendrocyte Injury in Multiple Sclerosis: Molecular Mechanisms and Therapeutic Interventions
Critical Reviews™ in Immunology, Vol.22, 2002, issue 5-6
Piet Stinissen, Marcel Ameloot, Mieke Buntinx, Jef Raus, Paul Steels
Pathogen-Associated Molecular Pattern in Cancer Immunotherapy
Critical Reviews™ in Immunology, Vol.28, 2008, issue 2
Uwe Hobohm, John M. Grange, John L. Stanford
The Nature of Reed-Sternberg Cells: Phenotype, Genotype, and Other Properties
Critical Reviews™ in Oncogenesis, Vol.5, 1994, issue 2-3
Su-Ming Hsu, Pei-Ling Hsu
The Ambivalent Nature of T-Cell Infiltration in the Central Nervous System of Patients with Multiple Sclerosis
Critical Reviews™ in Immunology, Vol.27, 2007, issue 1
Jerome J. A. Hendriks, Joris Vanderlocht, Piet Stinissen, Niels Hellings
The Proteasome and Its Inhibitors in Immune Regulation and Immune Disorders
Critical Reviews™ in Immunology, Vol.26, 2006, issue 6
Alberto Ballestrero, Franco Patrone, Frank Grunebach, Alessio Nencioni, Peter Brossart